$1.800
-
(-%)
Delayed prices. Updated at 08 Sep 2026 16:00.
1.800
Open Price
1.800
Previous Close Price
4,379.637
Market Cap (M)
1.660 - 2.550 (53.61%)
52 Weeks Range
-
Volume (K)

About the Company

Sector & Industry Health Technology | Pharmaceuticals: Major
Category Classification Medical & Biotechnology
Under CPF Investment Scheme (CPFIS) No
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, and MOVICOL. It operates through the Integrated Business and Skin Health Business segments. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.

Loading Chart...

Please login to view stock data and analysis
Please login to view stock data and analysis